Every 8-K that Intel Corp (INTC) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 8-K covers material events a company has to report between its quarterly reports, so if you follow INTC and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full INTC filings page.
Intel Corporation entered into an underwriting agreement to issue and sell 210,526,315 shares of common stock at $95.00 per share in an underwritten public offering, which was upsized to a total offering size of $20 billion from a previously announced $15 billion.
The underwriters received a 30-day option to purchase up to an additional 31,578,947 shares, which was exercised in full on August 11, 2026. Intel expects net proceeds of approximately $19.7 billion assuming no option exercise, and intends to use the funds for general corporate purposes, including capital expenditures and working capital, to pursue growth opportunities in AI-related markets while supporting a strong balance sheet and an investment-grade rating.
Intel Corporation reported Q2 2026 revenue of $16.1 billion, up 25% year over year, with GAAP gross margin improving to 40.4% from 27.5% and non-GAAP gross margin to 41.8%.
GAAP results showed a net loss attributable to Intel of $11.0 billion, or $(2.16) per diluted share, largely reflecting a $12,529 million mark-to-market loss on Escrowed Shares related to a CHIPS Act Secure Enclave agreement. On a non-GAAP basis, net income attributable to Intel was $2.2 billion, or $0.42 per diluted share, compared with a loss a year earlier.
Client Computing and Physical AI revenue was $8.9 billion, up 13%, Data Center and AI revenue was $6.3 billion, up 59%, and Intel Foundry revenue was $5.8 billion, up 31%. Operating cash flow in the quarter was $7.0 billion, while adjusted free cash flow was negative $8,419 million. For Q3 2026, Intel forecasts revenue of $15.8–16.8 billion, GAAP EPS of $0.31 and non-GAAP EPS of $0.38, based on a 41.0% GAAP and 42.0% non-GAAP gross margin.
Intel Corporation reported the results of its annual stockholder meeting held on May 13, 2026. A total of 3,972,192,463 shares were present or represented by proxy, representing 79.11% of the 5,021,010,228 shares outstanding as of March 16, 2026.
All 11 director nominees were elected, each receiving a substantial majority of votes cast. Stockholders approved the ratification of the independent registered public accounting firm, the advisory vote on executive compensation, and amendments and restatements to both the 2006 Equity Incentive Plan and the 2006 Employee Stock Purchase Plan.
Three stockholder proposals did not pass: a request for a report on risk of China exposure, a report on Intel's human rights due diligence process, and an enduring policy to separate the chair and CEO roles. Each of these proposals received significantly more votes against than for, with sizable broker non-votes recorded.
Intel Corporation issued $6.5 billion of senior notes as long-term debt financing. The issuance includes $1.0 billion of 4.650% Senior Notes due 2031, $1.0 billion of 5.000% Senior Notes due 2033, $2.25 billion of 5.300% Senior Notes due 2036, $1.75 billion of 6.125% Senior Notes due 2056, and $500 million of 6.200% Senior Notes due 2066. Intel received approximately $6.47 billion in net proceeds after underwriting discounts, before expenses, under a previously filed shelf registration and existing indenture framework.
Intel Corporation reported a leadership change in its finance organization. On April 24, 2026, Corporate Vice President and Chief Accounting Officer Scott Gawel resigned as principal accounting officer, effective immediately, to pursue another career opportunity.
At the same time, Executive Vice President and Chief Financial Officer David A. Zinsner assumed the additional role of principal accounting officer while continuing as principal financial officer. The filing also includes a cover page data file formatted in Inline XBRL as an exhibit.
Intel Corporation reported first-quarter 2026 results with stronger revenue but a large GAAP loss driven by restructuring. Revenue reached $13.6 billion, up 7% year-over-year, with Intel Products revenue of $12.8 billion up 9%. Client Computing Group revenue was $7.7 billion, up 1%, while Data Center and AI revenue rose to $5.1 billion, up 22%, reflecting AI-related CPU demand.
GAAP results showed a net loss attributable to Intel of $3.7 billion and diluted EPS of $(0.73), pressured by $4.1 billion in restructuring and other charges, including a Mobileye goodwill impairment, plus mark-to-market losses on Escrowed Shares and higher interest expense. On a non-GAAP basis, net income attributable to Intel was $1.5 billion and diluted EPS was $0.29, up from $0.13.
GAAP gross margin improved to 39.4% from 36.9%, and non-GAAP gross margin rose to 41.0%. Intel generated $1.1 billion in operating cash flow but reported adjusted free cash flow of $(2.0) billion as it continued heavy capital investment. For the second quarter of 2026, Intel forecasts revenue of $13.8–$14.8 billion, GAAP diluted EPS of $0.08, and non-GAAP diluted EPS of $0.20, with a GAAP gross margin of 37.5% and non-GAAP gross margin of 39.0%.
Intel Corporation repurchased for $14.2 billion the 49% equity interest that Apollo-managed funds and affiliates held in the joint venture for Intel’s Fab 34 in Ireland. Intel financed the deal with cash on hand and a $6.5 billion bridge loan that it intends to refinance, subject to market conditions.
Following the transaction, Intel owns 100% of the Fab 34 joint venture. The structure had been created in June 2024, and Intel now expects to terminate the ancillary agreements governing construction, operation, and wafer purchase and to wind up the joint venture.
Intel Corporation announced that Executive Vice President and Chief Legal Officer April Miller Boise will leave the company effective June 1, 2026. Intel’s board determined her separation on March 30, 2026.
Upon her departure, Ms. Miller Boise will receive severance benefits under the previously disclosed Intel Corporation Executive Severance Plan, in exchange for providing a release of claims in favor of Intel. No other leadership changes or financial results are described in this report.
Intel Corporation announced that Board Chair Frank D. Yeary will retire from the board and not stand for reelection at the 2026 Annual Meeting of Stockholders. At the conclusion of that meeting, the board size will be reduced from twelve to eleven directors.
The board has elected Dr. Craig H. Barratt as independent chair, effective following the Annual Stockholders’ Meeting on May 13, 2026. Barratt joined the board in November 2025 and brings more than three decades of semiconductor and technology leadership experience at companies including Qualcomm, Intel, Google, Atheros Communications, Barefoot Networks, Intuitive Surgical and Astera Labs.
Intel’s leadership emphasized that Yeary helped guide the company through a period of strategic transformation, including the appointment of CEO Lip-Bu Tan and progress on Intel’s technology roadmap such as Intel 18A and 14A. Since 2024, Intel has added four new independent directors as part of an intentional board refresh aligned with priorities in technology leadership, operational excellence and capital discipline.
Intel Corporation filed a current report describing an update to its resale registration for certain shares of common stock and a warrant held by the U.S. Department of Commerce. On January 23, 2026, Intel filed a new prospectus supplement that replaces a prior supplement from September 5, 2025, moving the registration of the same securities to Intel’s new automatic shelf registration statement on Form S-3ASR.
The filing emphasizes that no new securities have been issued or will become issuable to the Department of Commerce under this update. The prospectus supplement is for potential resale by the Department of Commerce, and Intel will not issue or sell any securities under it and would not receive any proceeds if the selling securityholder chooses to sell its securities. Intel also includes a legal opinion from Skadden, Arps, Slate, Meagher & Flom LLP on the validity of the common stock and warrant covered by the resale prospectus supplement.
Intel Corporation filed a current report to note that it has released its financial results for the fourth quarter ended December 27, 2025. On January 22, 2026, the company issued a press release detailing these results and providing forward-looking statements for its first quarter of 2026, which is attached as Exhibit 99.1.
The press release uses both GAAP and non-GAAP financial measures, and includes reconciliations between them. Intel explains how management uses these non-GAAP metrics and why it believes they offer useful information to investors. The earnings information and related press release are being furnished rather than filed under the Exchange Act.
Intel Corporation appointed Dr. Craig H. Barratt to its Board of Directors, effective November 10, 2025. The Board determined he is “independent” under Nasdaq rules. Barratt brings decades of semiconductor and technology leadership, including CEO roles at Atheros and Barefoot Networks, senior roles at Qualcomm and Google, and current directorships at Intuitive Surgical and Astera Labs.
He will receive standard non‑employee director compensation, including a time‑based RSU grant of approximately $125,000 to be awarded in Q1 2026 and vesting on the earlier of May 7, 2026 or Intel’s 2026 Annual Stockholders’ Meeting, subject to continued service.
Intel Corporation furnished an 8-K to announce its third-quarter 2025 financial results and provide forward-looking statements for the fourth quarter. The quarter ended on September 27, 2025. A press release titled “Intel Reports Third-Quarter 2025 Financial Results” is attached as Exhibit 99.1 and incorporated by reference.
The press release includes non-GAAP financial measures with reconciliations to GAAP and an explanation of how management uses these metrics. The information in Item 2.02 and Exhibit 99.1 is furnished and not filed under the Exchange Act.
Intel Corporation completed a private placement issuing 86,956,522 shares of common stock at $23.00 per share to SoftBank Group Corp., raising approximately $2.0 billion in cash. The shares have a par value of $0.001 each. The transaction was effected under a Securities Purchase Agreement dated August 28, 2025, and relied on the Section 4(a)(2) exemption from registration as a transaction not involving a public offering. The company previously disclosed the proposed transaction in a Current Report filed August 21, 2025.
Intel Corporation entered into a Securities Purchase Agreement with NVIDIA Corporation on September 15, 2025, under which NVIDIA agreed to purchase 214,776,632 shares of Intel common stock at $23.28 per share, representing an aggregate purchase price of $5.0 billion in a private placement relying on Section 4(a)(2) of the Securities Act of 1933. The purchase is conditioned on customary closing conditions, including expiration of waiting periods and any required approvals under the Hart-Scott-Rodino Antitrust Improvements Act. The agreement contains customary representations, warranties and covenants and does not grant NVIDIA any governance or information rights beyond those of Intel shareholders generally. Intel furnished a press release dated September 18, 2025, announcing the private placement and a collaboration between Intel and NVIDIA to develop AI infrastructure and personal computing products; that press release is provided as Exhibit 99.1 to the Current Report.
Intel completed a majority-sale of its Altera business and adjusted its operating expense targets. Intel and an affiliate of Silver Lake entered a transaction agreement on April 14, 2025, and closed the transaction on September 12, 2025. The purchaser acquired 51% of Altera for an equity value of approximately $3.3 billion, while Intel retained a 49% interest and contributed both parties' interests into a newly formed limited partnership governed by an amended and restated LPA. Intel's consolidated financial statements for Q3 2025 will include Altera's results from June 29, 2025 through September 11, 2025; after closing on September 12, Intel will account for its minority investment under the equity method. Altera's results as a segment in H1 2025 showed revenue of $816 million, gross margin of 55%, and operating expenses of $356 million. Intel revised its full-year 2025 non-GAAP operating expense target to $16.8 billion (from $17 billion) to reflect Altera's deconsolidation; the full-year 2026 operating expense target remains $16 billion. The filing reiterates a range of business risks disclosed elsewhere.
Intel Corporation disclosed that Michelle Johnston Holthaus, Chief Executive Officer of Intel Products, notified the company on September 7, 2025 that she will resign for "Good Reason" under her Offer Letter dated February 28, 2025. She agreed to remain in a non-executive transition role through March 1, 2026 to support handover activities. Upon departure, she will be eligible for severance benefits under the Intel Corporation Executive Severance Plan in exchange for a release of claims. The report lists exhibits under Financial Statements and Exhibits but does not include additional financial metrics or compensation amounts.
Intel Corporation filed a prospectus supplement on September 5, 2025 to register the potential resale by the United States Department of Commerce of a warrant and 673,839,150 shares of common stock. The Warrant permits purchase of up to 240,516,150 shares at an initial exercise price of $20.00 per share. The 673,839,150 shares consist of 274,583,000 shares issued to the selling securityholder, 158,740,000 shares held in escrow subject to conditions in the Purchase Agreement, and 240,516,150 shares issuable upon exercise of the Warrant. The prospectus supplement was filed under Intel’s existing Form S-3ASR shelf registration. The filing itself is not a sale, would not generate proceeds for Intel if the selling securityholder sells, and no securities are being issued or sold by Intel under the supplement. A legal opinion as to the validity of the shares and the Warrant is attached as Exhibit 5.1 and is incorporated by reference.
Intel entered into an Implementing Amendment to its Direct Funding Agreement with the U.S. Department of Commerce that removes prior project milestone conditions and several other contractual restrictions while preserving key CHIPS Act limitations. The company certified it has already spent at least $7.865 billion in eligible costs under the agreement.
Concurrently, at closing under a related Purchase Agreement, Intel received accelerated DFA disbursements of $5.695 billion and issued the DOC 274,583,000 shares of common stock plus a warrant to buy up to 240,516,150 shares; an additional 158,740,000 shares were placed into escrow to be released as further CHIPS Act disbursements are made. Remaining DFA and CHIPS Act constraints still prohibit use of award funds for dividends or buybacks, limit certain foreign expansions and collaborations, and preserve remedies for the DOC in the event of breach, including potential repayment of awards.
Intel Corporation entered a Purchase Agreement with the U.S. Department of Commerce (DOC) under which the company agreed to issue up to 433,323,000 shares of common stock: 274,583,000 shares to be issued on the Closing Date (based on $20.74 per share if all Released Funds are received) and 158,740,000 shares to be held in escrow and released as Secure Enclave Disbursements are received (priced at $20.00 per share). The DOC will also receive warrants exercisable for up to 240,516,150 shares at an exercise price of $20.00 per share; warrants vest and become exercisable only if Intel ceases to directly or indirectly own at least 51% of its foundry business, and expire five years after closing.
The Purchase Agreement contemplates a Closing Date of August 26, 2025 (or as soon as practicable thereafter). Securities will be non-transferable by the DOC until after the first anniversary of closing and subject to restrictions thereafter. The Company must file a resale registration statement with the SEC on or before September 5, 2025. The filing also adds risk factors describing timing and funding uncertainties, potential dilution to existing stockholders, governance and voting impacts from significant DOC ownership, possible adverse effects on non-U.S. business, and other consequences from government ownership.
Intel Corporation announced it entered into a Securities Purchase Agreement with SoftBank Group Corp. under which SoftBank agreed to buy 86,956,522 shares of Intel common stock for an aggregate cash purchase price of $2.0 billion, equal to $23.00 per share. The Shares will be issued in a private placement relying on Section 4(a)(2) of the Securities Act of 1933 as a transaction not involving a public offering. The Purchase Agreement contains customary representations, warranties and covenants, and closing is subject to customary conditions, including expiration or termination of applicable waiting periods and any required approvals under the Hart-Scott-Rodino Antitrust Improvements Act of 1976. The company furnished a press release dated August 18, 2025 as Exhibit 99.1 to the Current Report.
Intel and related parties amended their April 14, 2025 transaction agreement to sell a majority interest in the Altera business. Amendment No. 1, entered August 11, 2025, makes technical changes to the purchase price calculation that the company does not expect to materially affect net cash proceeds. The amendment also shifts the earliest allowable closing to no earlier than September 12, 2025 and extends the outside closing date to September 13, 2025, providing additional time to satisfy closing conditions. The filing reiterates standard forward-looking disclosures and lists potential risks that could prevent or delay completion.